David N. Gordon is Chief Medical Officer of Aclaris Therapeutics, Inc.. Currently has a direct ownership of 147,447 shares of ACRS, which is worth approximately $430,545. The most recent transaction as insider was on Jul 13, 2021, when has been sold 2,631 shares (Common Stock) at a price of $16.98 per share, resulting in proceeds of $44,674. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 147K
0% 3M change
0% 12M change
Total Value Held $430,545

David N. Gordon Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 13 2021
SELL
Open market or private sale
$44,674 $16.98 p/Share
2,631 Reduced 1.75%
147,447 Common Stock
Jul 02 2021
BUY
Exercise of conversion of derivative security
-
6,000 Added 3.84%
150,078 Common Stock
Jun 02 2021
SELL
Open market or private sale
$829,558 $21.88 p/Share
37,914 Reduced 20.83%
144,078 Common Stock
Jun 01 2021
SELL
Open market or private sale
$323,960 $23.14 p/Share
14,000 Reduced 7.14%
181,992 Common Stock
Jun 01 2021
BUY
Exercise of conversion of derivative security
-
87,500 Added 30.87%
195,992 Common Stock
Mar 02 2021
SELL
Payment of exercise price or tax liability
$53,010 $23.25 p/Share
2,280 Reduced 2.06%
108,492 Common Stock
Mar 02 2021
BUY
Exercise of conversion of derivative security
-
8,297 Added 6.97%
110,772 Common Stock
Mar 01 2021
SELL
Payment of exercise price or tax liability
$136,180 $24.06 p/Share
5,660 Reduced 5.23%
102,475 Common Stock
Mar 01 2021
BUY
Exercise of conversion of derivative security
-
20,600 Added 16.0%
108,135 Common Stock
DNG

David N. Gordon

Chief Medical Officer
Wayne, PA

Track Institutional and Insider Activities on ACRS

Follow Aclaris Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACRS shares.

Notify only if

Insider Trading

Get notified when an Aclaris Therapeutics, Inc. insider buys or sells ACRS shares.

Notify only if

News

Receive news related to Aclaris Therapeutics, Inc.

Track Activities on ACRS